{
  "author": {
    "name": "Emma Court",
    "webUrl": "/author/profile/emma-court/",
    "description": "",
    "imageLarge": "https://secure.gravatar.com/avatar/f16d6fc2845f417ea0e93a3f2b6cd37d?s=136&d=mm&r=g",
    "estimate": 10,
    "social": [],
    "articles": [
      {
        "uri": "/2023/06/27/the-race-is-on-some-drugmakers-falling-behind-in-developing-new-weight-loss-pills/",
        "title": "The race is on: Some drugmakers falling behind in developing new weight loss pills",
        "byline": "Emma Court, Robert Langreth and Matthew Griffin",
        "kicker": "Update",
        "prettyDate": "June 27, 2023",
        "timeToRead": "5 minute",
        "image": {
          "uri": "https://images.benefitspro.com/contrib/content/uploads/sites/412/2023/06/Medical-Research-Scientists-Article-202306270840.jpg",
          "width": "620",
          "height": "372"
        },
        "authors": [
          {
            "webUrl": "/author/profile/emma-court-robert-langreth/",
            "name": "Emma Court, Robert Langreth"
          },
          {
            "webUrl": "/author/profile/matthew-griffin/",
            "name": "Matthew Griffin"
          }
        ],
        "kickerNode": [
          {
            "uri": "/update/",
            "sectionName": "Update"
          }
        ],
        "summary": "Drugmakers have been rushing to develop obesity pills (to rival obesity shots like Wegovy), angling for a piece of a market that some estimate will one day be worth as much as $100 billion.",
        "body": null
      },
      {
        "uri": "/2023/05/25/weight-loss-startup-noom-now-prescribing-injectable-drugs-like-wegovy/",
        "title": "Weight loss startup Noom now prescribing injectable drugs like Wegovy",
        "byline": "Emma Court",
        "kicker": "News",
        "prettyDate": "May 25, 2023",
        "timeToRead": "5 minute",
        "image": {
          "uri": "https://images.benefitspro.com/contrib/content/uploads/sites/412/2020/07/Injection-Article-202007222110.jpg",
          "width": "620",
          "height": "372"
        },
        "authors": [
          {
            "webUrl": "/author/profile/emma-court/",
            "name": "Emma Court"
          }
        ],
        "kickerNode": [
          {
            "uri": "/news/",
            "sectionName": "News"
          }
        ],
        "summary": "After a pilot program last year, the company is launching its Noom Med option – available in 32 states – that will include prescriptions for Ozempic, Wegovy, Mounjaro and other GLP-1 obesity drugs for about $120 a month.",
        "body": null
      },
      {
        "uri": "/2023/04/27/eli-lillys-new-weight-loss-drug-could-eclipse-ozempic-as-the-most-powerful-treatment/",
        "title": "Eli Lilly's new weight loss drug could eclipse Ozempic as the most powerful treatment",
        "byline": "Emma Court and Nacha Cattan",
        "kicker": "News",
        "prettyDate": "April 27, 2023",
        "timeToRead": "4 minute",
        "image": {
          "uri": "https://images.benefitspro.com/contrib/content/uploads/sites/412/2020/07/Injection-Article-202007222110.jpg",
          "width": "620",
          "height": "372"
        },
        "authors": [
          {
            "webUrl": "/author/profile/emma-court/",
            "name": "Emma Court"
          },
          {
            "webUrl": "/author/profile/nacha-cattan/",
            "name": "Nacha Cattan"
          }
        ],
        "kickerNode": [
          {
            "uri": "/news/",
            "sectionName": "News"
          }
        ],
        "summary": "The pharmaceutical company is pushing for fast-track FDA approval of its diabetes drug Mounjaro for obesity today, after releasing promising clinical trial data that validates its claims for weight loss.",
        "body": null
      },
      {
        "uri": "/2023/03/16/novo-nordisk-cuts-insulin-prices-following-move-by-eli-lilly/",
        "title": "Novo Nordisk cuts insulin prices, following move by Eli Lilly",
        "byline": "Ilena Peng and Emma Court",
        "kicker": "News",
        "prettyDate": "March 16, 2023",
        "timeToRead": "5 minute",
        "image": {
          "uri": "https://images.benefitspro.com/contrib/content/uploads/sites/412/2020/02/InsulinSyringe.jpg",
          "width": "600",
          "height": "400"
        },
        "authors": [
          {
            "webUrl": "/author/profile/ilena-peng/",
            "name": "Ilena Peng"
          },
          {
            "webUrl": "/author/profile/emma-court/",
            "name": "Emma Court"
          }
        ],
        "kickerNode": [
          {
            "uri": "/news/",
            "sectionName": "News"
          }
        ],
        "summary": "Under mounting pressure, Novo Nordisk plans to cut list prices for insulin products by up to 75%, now the latest drugmaker to take such a step following a California lawsuit accusing drugmakers of driving up costs.",
        "body": null
      },
      {
        "uri": "/2022/04/15/companies-are-loosening-vaccination-guidelines-but-is-that-a-good-thing/",
        "title": "Companies are loosening vaccination guidelines, but is that a good thing?",
        "byline": "Emma Court",
        "kicker": "News",
        "prettyDate": "April 15, 2022",
        "timeToRead": "8 minute",
        "image": {
          "uri": "https://images.benefitspro.com/contrib/content/uploads/sites/412/2022/03/Return-to-Office-Article-202108120722.jpg",
          "width": "620",
          "height": "372"
        },
        "authors": [
          {
            "webUrl": "/author/profile/emma-court/",
            "name": "Emma Court"
          }
        ],
        "kickerNode": [
          {
            "uri": "/news/",
            "sectionName": "News"
          }
        ],
        "summary": "As virus rates appear to ebb and companies loosen rules, they could be alienating employees who dutifully got their shots.",
        "body": null
      },
      {
        "uri": "/2020/10/30/covid-continues-to-put-a-damper-on-health-pharma-industries/",
        "title": "COVID continues to put a damper on health, pharma industries",
        "byline": "Emma Court, Robert Langreth, John Tozzi and Riley Griffin",
        "kicker": "Market Insights",
        "prettyDate": "October 30, 2020",
        "timeToRead": "6 minute",
        "image": {
          "uri": "https://images.benefitspro.com/contrib/content/uploads/sites/412/2020/10/covid-19-coronavirus-economy-money-chart-stocks.jpg",
          "width": "0",
          "height": "0"
        },
        "authors": [
          {
            "webUrl": "/author/profile/emma-court-robert-langreth-john-tozzi/",
            "name": "Emma Court, Robert Langreth, John Tozzi"
          },
          {
            "webUrl": "/author/profile/riley-griffin/",
            "name": "Riley Griffin"
          }
        ],
        "kickerNode": [
          {
            "uri": "/market-insights/",
            "sectionName": "Market Insights"
          }
        ],
        "summary": "For drugmakers, the pandemic has squeezed demand for everything from childhood vaccines to smoking-cessation drugs.",
        "body": null
      },
      {
        "uri": "/2020/07/07/employee-covid-testing-worth-the-effort/",
        "title": "Employee COVID testing: Worth the effort?",
        "byline": "Emma Court, Christopher Palmeri and Angelica LaVito",
        "kicker": "News",
        "prettyDate": "July 07, 2020",
        "timeToRead": "8 minute",
        "image": {
          "uri": "https://images.benefitspro.com/contrib/content/uploads/sites/412/2020/05/COVIDTestShutterstock.jpg",
          "width": "620",
          "height": "372"
        },
        "authors": [
          {
            "webUrl": "/author/profile/emma-court-christopher-palmeri/",
            "name": "Emma Court, Christopher Palmeri"
          },
          {
            "webUrl": "/author/profile/angelica-lavito/",
            "name": "Angelica LaVito"
          }
        ],
        "kickerNode": [
          {
            "uri": "/news/",
            "sectionName": "News"
          }
        ],
        "summary": "Bogged down by the logistics of testing, employers are favoring lower-cost, easier-to-implement interventions like temperature checks.",
        "body": null
      },
      {
        "uri": "/2020/05/07/unitedhealth-other-insurers-offer-discounts-to-customers-hit-by-covid-19/",
        "title": "UnitedHealth, other insurers offer discounts to customers hit by COVID-19",
        "byline": "John Tozzi and Emma Court",
        "kicker": "News",
        "prettyDate": "May 07, 2020",
        "timeToRead": "5 minute",
        "image": {
          "uri": "https://images.benefitspro.com/contrib/content/uploads/sites/412/2019/11/United-HealthCare-Article-201810172221.jpg",
          "width": "620",
          "height": "372"
        },
        "authors": [
          {
            "webUrl": "/author/profile/john-tozzi/",
            "name": "John Tozzi"
          },
          {
            "webUrl": "/author/profile/emma-court/",
            "name": "Emma Court"
          }
        ],
        "kickerNode": [
          {
            "uri": "/news/",
            "sectionName": "News"
          }
        ],
        "summary": "Insurers have been experiencing a short-term increase in profits and are passing those savings back.",
        "body": null
      },
      {
        "uri": "/2020/01/30/electronic-health-records-company-played-a-part-in-pushing-opioids/",
        "title": "Electronic health records company played a part in pushing opioids",
        "byline": "Emma Court",
        "kicker": "News",
        "prettyDate": "January 30, 2020",
        "timeToRead": "6 minute",
        "image": {
          "uri": "https://images.benefitspro.com/contrib/content/uploads/sites/412/2018/09/OpioidsFentanyl.jpg",
          "width": "616",
          "height": "372"
        },
        "authors": [
          {
            "webUrl": "/author/profile/emma-court/",
            "name": "Emma Court"
          }
        ],
        "kickerNode": [
          {
            "uri": "/news/",
            "sectionName": "News"
          }
        ],
        "summary": "Software company Practice Fusion was paid by a major opioid manufacturer to design a tool to boost prescriptions.",
        "body": null
      },
      {
        "uri": "/2019/11/07/millennials-health-problems-taking-an-economic-toll/",
        "title": "Millennials' health problems taking an economic toll",
        "byline": "Emma Court",
        "kicker": "Market Insights",
        "prettyDate": "November 07, 2019",
        "timeToRead": "4 minute",
        "image": {
          "uri": "https://images.benefitspro.com/contrib/content/uploads/sites/412/2019/06/WomanDoctorOfficeShutterstock.jpg",
          "width": "616",
          "height": "372"
        },
        "authors": [
          {
            "webUrl": "/author/profile/emma-court/",
            "name": "Emma Court"
          }
        ],
        "kickerNode": [
          {
            "uri": "/market-insights/",
            "sectionName": "Market Insights"
          }
        ],
        "summary": "A spike in conditions like depression, hypertension and high cholesterol could increase health care costs and lower incomes.",
        "body": null
      }
    ]
  }
}